|
ProPublica: Safety questions over GSK's Advair linger after years on the …
FiercePharma Recent research suggests that a significant percentage of asthma patients begin using Advair inappropriately, the watchdog says, and that can trigger the "risk of asthma-related death" described on the med's label. And while the FDA in 2010 required … |
View full post on asthma – Google News